Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective
暂无分享,去创建一个
S. Molin | A. Folkesson | N. Høiby | H. Johansen | L. Jelsbak | O. Ciofu | Lei Yang
[1] C. von Buchwald,et al. Colonisation and infection of the paranasal sinuses in cystic fibrosis patients is accompanied by a reduced PMN response. , 2012, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[2] D. Ohman,et al. Identification of Genes in the σ22 Regulon of Pseudomonas aeruginosa Required for Cell Envelope Homeostasis in Either the Planktonic or the Sessile Mode of Growth , 2012, mBio.
[3] G. Beslon,et al. New insights into bacterial adaptation through in vivo and in silico experimental evolution , 2012, Nature Reviews Microbiology.
[4] Susan Murray,et al. Decade-long bacterial community dynamics in cystic fibrosis airways , 2012, Proceedings of the National Academy of Sciences.
[5] C. von Buchwald,et al. CT of the paranasal sinuses is not a valid indicator for sinus surgery in CF patients. , 2012, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[6] H. Goossens,et al. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists , 2012, Rhinology journal.
[7] Joanna B. Goldberg,et al. Parallel bacterial evolution within multiple patients identifies candidate pathogenicity genes , 2011, Nature Genetics.
[8] Forest Rohwer,et al. Spatial distribution of microbial communities in the cystic fibrosis lung , 2011, The ISME Journal.
[9] Nathan E Lewis,et al. Microbial laboratory evolution in the era of genome-scale science , 2011, Molecular systems biology.
[10] S. Molin,et al. Microbial ecology and adaptation in cystic fibrosis airways. , 2011, Environmental microbiology.
[11] S. Molin,et al. Evolution and diversification of Pseudomonas aeruginosa in the paranasal sinuses of cystic fibrosis children have implications for chronic lung infection , 2011, The ISME Journal.
[12] M. Brockhurst,et al. Pseudomonas aeruginosa population diversity and turnover in cystic fibrosis chronic infections. , 2011, American journal of respiratory and critical care medicine.
[13] J. Klockgether,et al. 152* Microevolution of the major common Pseudomonas aeruginosa clones C and PA14 in cystic fibrosis lungs , 2011, Journal of Cystic Fibrosis.
[14] Lutz Wiehlmann,et al. Pseudomonas aeruginosa Genomic Structure and Diversity , 2011, Front. Microbio..
[15] Anders Folkesson,et al. Evolutionary dynamics of bacteria in a human host environment , 2011, Proceedings of the National Academy of Sciences.
[16] Jeffrey E. Barrick,et al. Second-Order Selection for Evolvability in a Large Escherichia coli Population , 2011, Science.
[17] M. Davey,et al. The activity and hydrogen peroxide sensitivity of the peroxiredoxins from the parasitic nematode Haemonchus contortus. , 2011, Molecular and biochemical parasitology.
[18] C. von Buchwald,et al. Decreased mucosal oxygen tension in the maxillary sinuses in patients with cystic fibrosis. , 2011, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[19] S. McColley,et al. Clinical Significance of Microbial Infection and Adaptation in Cystic Fibrosis , 2011, Clinical Microbiology Reviews.
[20] J. Heesemann,et al. Adaptation of Pseudomonas aeruginosa during persistence in the cystic fibrosis lung. , 2010, International journal of medical microbiology : IJMM.
[21] B. Tümmler,et al. Clonal epidemiology of Pseudomonas aeruginosa in cystic fibrosis. , 2010, International journal of medical microbiology : IJMM.
[22] A. Bush,et al. Airway remodelling and its relationship to inflammation in cystic fibrosis , 2010, Thorax.
[23] Edward M. Marcotte,et al. Parallel Evolution in Pseudomonas aeruginosa over 39,000 Generations In Vivo , 2010, mBio.
[24] M. Urbanowski,et al. Activation of the Pseudomonas aeruginosa AlgU Regulon through mucA Mutation Inhibits Cyclic AMP/Vfr Signaling , 2010, Journal of bacteriology.
[25] Lei Wang,et al. Divergence Involving Global Regulatory Gene Mutations in an Escherichia coli Population Evolving under Phosphate Limitation , 2010, Genome biology and evolution.
[26] Kristian Fog Nielsen,et al. Early adaptive developments of Pseudomonas aeruginosa after the transition from life in the environment to persistent colonization in the airways of human cystic fibrosis hosts. , 2010, Environmental microbiology.
[27] Eoin L. Brodie,et al. Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa. , 2010, Environmental microbiology.
[28] G. Pier,et al. Alveolar inflammation in cystic fibrosis. , 2010, Journal of Cystic Fibrosis.
[29] H. Arets,et al. Upper and lower airway cultures in children with cystic fibrosis: do not neglect the upper airways. , 2010, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[30] D. Hassett,et al. Pseudomonas aeruginosa biofilm infections in cystic fibrosis: insights into pathogenic processes and treatment strategies , 2010, Expert opinion on therapeutic targets.
[31] Jeffrey E. Barrick,et al. Genome evolution and adaptation in a long-term experiment with Escherichia coli , 2009, Nature.
[32] A. Kharazmi,et al. Polymorphonuclear leucocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa pneumonia in cystic fibrosis , 2009, Thorax.
[33] M. Schuster,et al. Instantaneous Within-Patient Diversity of Pseudomonas aeruginosa Quorum-Sensing Populations from Cystic Fibrosis Lung Infections , 2009, Infection and Immunity.
[34] Nancy D. Hanson,et al. Antibacterial-Resistant Pseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms , 2009, Clinical Microbiology Reviews.
[35] J. Gustafson,et al. Cystic Fibrosis , 2009, Journal of the Iowa Medical Society.
[36] C. Di Serio,et al. Pseudomonas aeruginosa microevolution during cystic fibrosis lung infection establishes clones with adapted virulence. , 2009, American journal of respiratory and critical care medicine.
[37] Axel Imhof,et al. Dynamics of adaptive microevolution of hypermutable Pseudomonas aeruginosa during chronic pulmonary infection in patients with cystic fibrosis. , 2009, The Journal of infectious diseases.
[38] N. Høiby,et al. Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients , 2009, Pediatric pulmonology.
[39] D. Ohman,et al. Use of cell wall stress to characterize σ22 (AlgT/U) activation by regulated proteolysis and its regulon in Pseudomonas aeruginosa , 2009, Molecular microbiology.
[40] J. Mainz,et al. Concordant genotype of upper and lower airways P aeruginosa and S aureus isolates in cystic fibrosis , 2009, Thorax.
[41] N. Høiby,et al. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience. , 2008, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[42] J. Robertson,et al. Nasal and sinus disease in cystic fibrosis. , 2008, Paediatric respiratory reviews.
[43] C Kleinstreuer,et al. Targeted drug-aerosol delivery in the human respiratory system. , 2008, Annual review of biomedical engineering.
[44] P. Hunter. The great leap forward , 2008, EMBO reports.
[45] R. Lenski,et al. Inaugural Article: Historical contingency and the evolution of a key innovation in an experimental population of Escherichia coli , 2008 .
[46] M. Berger,et al. Chronic Inflammation in the Cystic Fibrosis Lung: Alterations in Inter- and Intracellular Signaling , 2008, Clinical reviews in allergy & immunology.
[47] G. O’Toole,et al. In Vitro Analysis of Tobramycin-Treated Pseudomonas aeruginosa Biofilms on Cystic Fibrosis-Derived Airway Epithelial Cells , 2008, Infection and Immunity.
[48] S. Molin,et al. In Situ Growth Rates and Biofilm Development of Pseudomonas aeruginosa Populations in Chronic Lung Infections , 2007, Journal of bacteriology.
[49] F. Taddei,et al. Dissecting the Genetic Components of Adaptation of Escherichia coli to the Mouse Gut , 2007, PLoS genetics.
[50] S. Molin,et al. Characterization of a Pseudomonas putida Rough Variant Evolved in a Mixed-Species Biofilm with Acinetobacter sp. Strain C6 , 2007, Journal of bacteriology.
[51] Freya Harrison,et al. Microbial ecology of the cystic fibrosis lung. , 2007, Microbiology.
[52] L. Chao,et al. Understanding the Evolutionary Fate of Finite Populations: The Dynamics of Mutational Effects , 2007, PLoS biology.
[53] David A. D'Argenio,et al. Growth phenotypes of Pseudomonas aeruginosa lasR mutants adapted to the airways of cystic fibrosis patients , 2007, Molecular microbiology.
[54] N. Høiby,et al. Isolation measures for prevention of infection with respiratory pathogens in cystic fibrosis: a systematic review? , 2007, The Journal of hospital infection.
[55] Lars Jelsbak,et al. Molecular Epidemiology and Dynamics of Pseudomonas aeruginosa Populations in Lungs of Cystic Fibrosis Patients , 2007, Infection and Immunity.
[56] R. Austin,et al. Bacterial metapopulations in nanofabricated landscapes , 2006, Proceedings of the National Academy of Sciences.
[57] Steven R. Head,et al. Defining the Pseudomonas aeruginosa SOS Response and Its Role in the Global Response to the Antibiotic Ciprofloxacin , 2006, Journal of bacteriology.
[58] A. J. Leech,et al. Cell wall‐inhibitory antibiotics activate the alginate biosynthesis operon in Pseudomonas aeruginosa: roles of σ22 (AlgT) and the AlgW and Prc proteases , 2006, Molecular microbiology.
[59] C. Braggion,et al. Isolation measures for prevention of infection with respiratory pathogens in cystic fibrosis: a systematic review. , 2006, The Journal of hospital infection.
[60] A. Griffin,et al. Social evolution theory for microorganisms , 2006, Nature Reviews Microbiology.
[61] David A. D'Argenio,et al. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[62] Nigel F. Delaney,et al. Darwinian Evolution Can Follow Only Very Few Mutational Paths to Fitter Proteins , 2006, Science.
[63] M. Whiteley,et al. Microarray Analysis of the Osmotic Stress Response in Pseudomonas aeruginosa , 2006, Journal of bacteriology.
[64] G. Döring,et al. Eradication of Pseudomonas aeruginosa in cystic fibrosis patients , 2006, European Respiratory Journal.
[65] Edward A Graviss,et al. Genome-Wide Analysis of Group A Streptococci Reveals a Mutation That Modulates Global Phenotype and Disease Specificity , 2006, PLoS pathogens.
[66] J. Carlin,et al. Lower Airway Inflammation in Infants with Cystic Fibrosis Detected by Newborn Screening , 2005, Pediatric pulmonology.
[67] N. Høiby,et al. Eradication of early Pseudomonas aeruginosa infection. , 2005, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[68] D. Wozniak,et al. Understanding the control of Pseudomonas aeruginosa alginate synthesis and the prospects for management of chronic infections in cystic fibrosis , 2005, Molecular microbiology.
[69] K. Poole. Aminoglycoside Resistance in Pseudomonas aeruginosa , 2005, Antimicrobial Agents and Chemotherapy.
[70] Blaise R. Boles,et al. Self-generated diversity produces "insurance effects" in biofilm communities. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[71] H. Baker,et al. MucA-Mediated Coordination of Type III Secretion and Alginate Synthesis in Pseudomonas aeruginosa , 2004, Journal of bacteriology.
[72] M. Ranke,et al. Antioxidant deficiency in cystic fibrosis: when is the right time to take action? , 2004, The American journal of clinical nutrition.
[73] N. Høiby,et al. Early intervention and prevention of lung disease in cystic fibrosis: a European consensus. , 2004, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[74] P. Gøtzsche,et al. Antibody response to Pseudomonas aeruginosa in cystic fibrosis patients: A marker of therapeutic success?—A 30‐year Cohort study of survival in Danish CF patients after onset of chronic P. aeruginosa lung infection , 2004, Pediatric pulmonology.
[75] Martin Schuster,et al. Pseudomonas aeruginosa Biofilms Exposed to Imipenem Exhibit Changes in Global Gene Expression and β-Lactamase and Alginate Production , 2004, Antimicrobial Agents and Chemotherapy.
[76] J. Emerson,et al. Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosis. , 2003, American journal of respiratory and critical care medicine.
[77] M. Denton,et al. Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. , 2003, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[78] F. Ratjen,et al. Cystic fibrosis , 2003, The Lancet.
[79] U. Römling,et al. Impact of large chromosomal inversions on the adaptation and evolution of Pseudomonas aeruginosa chronically colonizing cystic fibrosis lungs , 2002, Molecular microbiology.
[80] Christian Koch,et al. Early infection and progression of cystic fibrosis lung disease , 2002, Pediatric pulmonology.
[81] C. Branger,et al. Identification of PSE and OXA beta-lactamase genes in Pseudomonas aeruginosa using PCR-restriction fragment length polymorphism. , 2002, The Journal of antimicrobial chemotherapy.
[82] Richard C Boucher,et al. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. , 2002, The Journal of clinical investigation.
[83] J. Bull,et al. Profiles of adaptation in two similar viruses. , 2001, Genetics.
[84] E. Bingen,et al. Genotypic characterization of Pseudomonas aeruginosa strains recovered from patients with cystic fibrosis after initial and subsequent colonization , 2001, Pediatric pulmonology.
[85] N. Høiby,et al. Characterization of paired mucoid/non-mucoid Pseudomonas aeruginosa isolates from Danish cystic fibrosis patients: antibiotic resistance, beta-lactamase activity and RiboPrinting. , 2001, The Journal of antimicrobial chemotherapy.
[86] V. Hudson. Rethinking cystic fibrosis pathology: the critical role of abnormal reduced glutathione (GSH) transport caused by CFTR mutation. , 2001, Free radical biology & medicine.
[87] J. Emerson,et al. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. , 2001, The Journal of infectious diseases.
[88] R. Lenski,et al. The population genetics of ecological specialization in evolving Escherichia coli populations , 2000, Nature.
[89] M. Hodson,et al. Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus. , 2000, The European respiratory journal.
[90] A. Oliver,et al. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. , 2000, Science.
[91] J. Burns,et al. Aminoglycoside-resistance mechanisms for cystic fibrosis Pseudomonas aeruginosa isolates are unchanged by long-term, intermittent, inhaled tobramycin treatment. , 2000, The Journal of infectious diseases.
[92] Michael Travisano,et al. Adaptive radiation in a heterogeneous environment , 1998, Nature.
[93] V. Deretic,et al. Mucoid Pseudomonas aeruginosa in cystic fibrosis: characterization of muc mutations in clinical isolates and analysis of clearance in a mouse model of respiratory infection , 1997, Infection and immunity.
[94] J. Hull,et al. Pulmonary oxidative stress response in young children with cystic fibrosis. , 1997, Thorax.
[95] V. Deretic,et al. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. , 1996, Microbiological reviews.
[96] M E Campbell,et al. Random amplified polymorphic DNA typing of Pseudomonas aeruginosa isolates recovered from patients with cystic fibrosis , 1996, Journal of clinical microbiology.
[97] P. Phelan,et al. Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis , 1995, BMJ.
[98] B. Tümmler,et al. Epidemiology of chronic Pseudomonas aeruginosa infections in cystic fibrosis. , 1994, The Journal of infectious diseases.
[99] D. Ohman,et al. Mucoid-to-nonmucoid conversion in alginate-producing Pseudomonas aeruginosa often results from spontaneous mutations in algT, encoding a putative alternate sigma factor, and shows evidence for autoregulation , 1994, Journal of bacteriology.
[100] D. Martin,et al. Analysis of promoters controlled by the putative sigma factor AlgU regulating conversion to mucoidy in Pseudomonas aeruginosa: relationship to sigma E and stress response , 1994, Journal of bacteriology.
[101] S. Fitzsimmons. The changing epidemiology of cystic fibrosis. , 1994, Current problems in pediatrics.
[102] D. Martin,et al. Conversion of Pseudomonas aeruginosa to mucoidy in cystic fibrosis: environmental stress and regulation of bacterial virulence by alternative sigma factors , 1994, Journal of bacteriology.
[103] C. Chitnis,et al. Genetic analysis of the alginate biosynthetic gene cluster of Pseudomonas aeruginosa shows evidence of an operonic structure , 1993, Molecular microbiology.
[104] D A Siegele,et al. Microbial competition: Escherichia coli mutants that take over stationary phase cultures. , 1993, Science.
[105] N. Høiby,et al. Seasonal onset of initial colonisation and chronic infection with Pseudomonas aeruginosa in patients with cystic fibrosis in Denmark. , 1992, Thorax.
[106] P. Gilligan,et al. Microbiology of airway disease in patients with cystic fibrosis , 1991, Clinical Microbiology Reviews.
[107] A. Kharazmi,et al. Pseudomonas aeruginosa alginate in cystic fibrosis sputum and the inflammatory response , 1990, Infection and immunity.
[108] D. Cabral,et al. Mucoid Pseudomonas aeruginosa Resists Nonopsonic Phagocytosis by Human Neutrophils and Macrophages , 1987, Pediatric Research.
[109] J. Sobel,et al. Phagocytosis of mucoid and nonmucoid strains of Pseudomonas aeruginosa. , 1984, Clinical immunology and immunopathology.
[110] T. Meshulam,et al. Opsonization and phagocytosis of mucoid and non-mucoidPseudomonas aeruginosa strains , 1982, European Journal of Clinical Microbiology.
[111] Herman Goossens,et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2012. , 2012, Rhinology. Supplement.
[112] Samuel I. Miller,et al. Pseudomonas aeruginosa lasR mutants are associated with cystic fibrosis lung disease progression. , 2009, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[113] R. Boucher. Relationship of airway epithelial ion transport to chronic bronchitis. , 2004, Proceedings of the American Thoracic Society.
[114] D. Martin,et al. Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[115] S. Pedersen,et al. Lung infection with alginate-producing, mucoid Pseudomonas aeruginosa in cystic fibrosis. , 1992, APMIS. Supplementum.
[116] R. Cowan,et al. Respiratory tract colonization with Pseudomonas aeruginosa in cystic fibrosis: Correlations between anti‐Pseudomonas aeruginosa antibody levels and pulmonary function , 1991, Pediatric pulmonology.
[117] R. Dean,et al. Scavenging by alginate of free radicals released by macrophages. , 1989, Free radical biology & medicine.
[118] J W Costerton,et al. The bacterial glycocalyx in nature and disease. , 1981, Annual review of microbiology.